Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Ionized plasmas as cheap sterilizers for developing world

16.11.2011
Low-temperature discharges generate oxygen, nitrogen radicals that kill microbes for week

University of California, Berkeley, scientists have shown that ionized plasmas like those in neon lights and plasma TVs not only can sterilize water, but make it antimicrobial – able to kill bacteria – for as long as a week after treatment.


A brief spark in air produces a low-temperature plasma of partially ionized and dissociated oxygen and nitrogen that will diffuse into nearby liquids or skin, where they can kill microbes similar to the way some drugs and immune cells kill microbes by generating similar or identical reactive chemicals. Credit: Steve Graves

Devices able to produce such plasmas are cheap, which means they could be life-savers in developing countries, disaster areas or on the battlefield where sterile water for medical use – whether delivering babies or major surgery – is in short supply and expensive to produce.

"We know plasmas will kill bacteria in water, but there are so many other possible applications, such as sterilizing medical instruments or enhancing wound healing," said chemical engineer David Graves, the Lam Research Distinguished Professor in Semiconductor Processing at UC Berkeley. "We could come up with a device to use in the home or in remote areas to replace bleach or surgical antibiotics."

Low-temperature plasmas as disinfectants are "an extraordinary innovation with tremendous potential to improve health treatments in developing and disaster-stricken regions," said Phillip Denny, chief administrative officer of UC Berkeley's Blum Center for Developing Economies, which helped fund Graves' research and has a mission of addressing the needs of the poor worldwide.

"One of the most difficult problems associated with medical facilities in low-resource countries is infection control," added Graves. "It is estimated that infections in these countries are a factor of three-to-five times more widespread than in the developed world."

Graves and his UC Berkeley colleagues published a paper in the November issue of the Journal of Physics D: Applied Physics, reporting that water treated with plasma killed essentially all the E. coli bacteria dumped in within a few hours of treatment and still killed 99.9 percent of bacteria added after it sat for seven days. Mutant strains of E. coli have caused outbreaks of intestinal upset and even death when they have contaminated meat, cheese and vegetables.

Based on other experiments, Graves and colleagues at the University of Maryland in College Park reported Oct. 31 at the annual meeting of the American Vacuum Society that plasma can also "kill" dangerous proteins and lipids – including prions, the infectious agents that cause mad cow disease – that standard sterilization processes leave behind.

In 2009, one of Graves' collaborators from the Max Planck Institute for Extraterrestrial Physics built a device capable of safely disinfecting human skin within seconds, killing even drug-resistant bacteria.

"The field of low-temperature plasmas is booming, and this is not just hype. It's real!" Graves said.

In the study published this month, Graves and his UC Berkeley colleagues showed that plasmas generated by brief sparks in air next to a container of water turned the water about as acidic as vinegar and created a cocktail of highly reactive, ionized molecules – molecules that have lost one or more electrons and thus are eager to react with other molecules. They identified the reactive molecules as hydrogen peroxide and various nitrates and nitrites, all well-known antimicrobials. Nitrates and nitrites have been used for millennia to cure meat, for example.

Graves was puzzled to see, however, that the water was still antimicrobial a week later, even though the peroxide and nitrite concentrations had dropped to nil. This indicated that some other reactive chemical – perhaps a nitrate – remained in the water to kill microbes, he said.

Plasma discharges have been used since the late 1800s to generate ozone for water purification, and some hospitals use low-pressure plasmas to generate hydrogen peroxide to decontaminate surgical instruments. Plasma devices also are used as surgical instruments to remove tissue or coagulate blood. Only recently, however, have low-temperature plasmas been used as disinfectants and for direct medical therapy, said Graves.

Graves recently focused on medical applications of plasmas after working for more than 20 years on low-temperature plasmas of the kind used to etch semiconductors. While sparks in air typically create hot plasmas of partially ionized and dissociated oxygen and nitrogen, a very brief spark creates similar molecules without heating the air. The reactive oxygen and nitrogen created by the plasma will diffuse into nearby liquids or skin, where they can kill microbes similar to the way some drugs and immune cells kill microbes by generating very similar or even identical reactive chemicals.

Despite the widespread use of plasmas, however, they are still not well characterized, Graves said. Plasma created in air, for example, produces different molecules than plasma in helium or argon. Much needs to be learned about different ways of producing plasmas, including plasma needles and jets, and how to maximize exposure against skin or liquid, such as by confining the plasma-generated chemicals near the surface of the treated object.

"I'm a chemical engineer who applies physics and chemistry to understanding plasmas," Graves said. "It's exciting to now look for ways to apply plasmas in medicine."

Graves' UC Berkeley coauthors are former post-doctoral fellow Matthew J. Traylor; graduate students Matthew J. Pavlovich and Sharmin Karim; undergraduate Pritha Hait; research associate Yukinori Sakiyama; and chemical engineer Douglas S. Clark, The Warren and Katharine Schlinger Distinguished Professor in Chemical Engineering and the chair of the Department of Chemical and Biomolecular Engineering.

The work on deactivating dangerous and persistent biological molecules was conducted with a group led by Gottlieb Oehrlein, a professor of materials science and engineering at the University of Maryland in College Park.

The research is supported by the U.S. Department of Energy's Office of Fusion Science Plasma Science Center, the UC Berkeley Blum Center for Developing Economies, and the UC Berkeley Sustainable Products and Solution Program.

Robert Sanders | EurekAlert!
Further information:
http://www.berkeley.edu

More articles from Physics and Astronomy:

nachricht SF State astronomer searches for signs of life on Wolf 1061 exoplanet
20.01.2017 | San Francisco State University

nachricht Molecule flash mob
19.01.2017 | Technische Universität Wien

All articles from Physics and Astronomy >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>